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STUDIES ON THE INHIBITION OF MELANIN FORMATION*
ALLAN L. LORINCZ, M.D.
After Raper (1) traced the series of chemical steps by which tyrosine is oxi-
dized to melanin by non-mammalian tyrosinases (Fig. 1) there appeared reports
about various chemical substances that inhibit this reaction at different stages
through various mechanisms. These reports have recently been reviewed by
Lerner and Fitzpatrick (2).
The present study deals with the mode of action of some chemical agents that
modify the melanin formation brought about by mammalian tyrosinase. This
investigation was undertaken in connection with a search for substances which
would be taken up selectively in melanoblasts by combining with intermediates
in the enzymatic process of tyrosine oxidation to form a precipitate. If such sub-
stances could be found it would make possible the selective destruction of mela-
nin-forming neoplastic cells.
METHODS
Mammalian tyrosinase extracts were prepared using the method of Lerner et
al (3) from mouse melanomas of the Cloudman S-91 variety (4)' after two to
three months' growth in dba strain mice. Using this enzyme, activity in melanin
forming systems buffered at pH 6.8 with 0.1 M potassium phosphate was deter-
mined manometrically in the presence of various inhibitors by measuring the
oxygen uptake in the Warburg respirometer at 38° C. Enzyme was added from
the side arms of the vessels to the buffered mixtures of substrate and inhibitor.
The tyrosinase potency of the enzyme preparations used in terms of Hogeboom-
Adams units (5) was approximately four units per cubic centimeter.
RESULTS AND COMMENTS
The observations of Lerner et al (3) about the induction period of mammalian
tyrosinase of Harding-Passey mouse melanoma origin were all found to be appli-
cable for the induction period of the enzyme preparation used here which was
derived from Cloudman mouse melanomas. Thus, with increasing tyrosine con-
centrations the induction period was prolonged while with increasing dopa (dihy-
droxyphenyl-L-alanine) concentrations it was shortened. For example, using
0.5 cc. of enzyme increasing the amount of tyrosine from one to ten micromoles
prolonged the induction period from thirty to one hundred minutes while with
0.2 cc. of enzyme and one micromole of tyrosine addition of 0.1 micromole of
dopa shortened the induction period from ninety to twenty minutes. From these
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results it is also evident that the enzyme preparation itself contains some factor
that shortens the induction period. With the enzyme acting on dopa alone no
induction period was demonstrable. Despite the differences in induction period
no appreciable changes in maximal rates of oxygen uptake were noted once the
the reactions were under way at each particular enzyme concentration.
Para-benzylhydroquinone
Para-benzylhydroquinone, a substance known to produce depigmentation in
human skin (6, 7, 8) was one of the compounds tested for its effect in modifying
FIG. 1. Enzymatic oxidation of tyrosine to melanin
the action of Cloudman melanoma tyrosinase. Previous workers (5, 7) had
studied the effect of this compound on tyrosine oxidation brought about by non-
mammalian tyrosinases and by Harding-Passey melanoma enzymes. The present
studies revealed the following facts which in some details differ from these pre-
vious observations: (1) When used alone as the substrate, p-benzylhydroquinone
is slowly oxidized without any latent period and with the consumption of approxi-
mately two and a half atoms of oxygen per molecule. The maximal rate of oxygen
uptake with 0.5 cc. of enzyme and one micromole of p-benzylhydroquinone is
about one-third the maximal rate for the same amount of enzyme with one micro-
mole of tyrosine. The final product of enzymatic p-benzylhydroquinone oxida-
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tion is a soluble red substance which can be dialyzed away from the enzyme-
substrate mixtures. (2) In equimolar concentration p-benzylhydroquinone does
not appreciably alter the rate of oxygen uptake in a system where enzyme acts
upon dopa. (3) P-benzylhydroquinone shortens the induction period for enzy-
matic tryosine oxidation. Furthermore, if different amounts of enzyme are used
when enzyme, tyrosine and p-benzylhydroquinone are incubated together, a
rather paradoxical behavior is observed. In the presence of small amounts of
FIG. 2. Curves A, B and C each represent oxygen uptake data with 0.5 cc. enzyme and
curves D and E with 0.2 cc. enzyme. In all cases one micromole of tyrosine was the sub-
strate. In addition, for Curve A there were present ten micromoles of p-benzylhydroquinone
and for Curves B and E one micromole pbenzylhydroquinone.
enzyme (0.2 cc.) the rate of oxygen uptake is slowed by the presence of p-benzyl-
hydroquinone. However, if large amounts of enzyme are used (0.5 cc.) oxygen
uptake in the system is accelerated even though the "inhibitor" is present in
large excess (Fig. 2). (4) In the presence of sufficient p-benzylhydroquinone the
final product of enzymatic tyrosine oxidation is a soluble red substance rather
than melanin. This material can be removed from the reaction mixture by dialy-
sis. It gives negative tests for the indole nucleus by Ehrlich's, Thormahlen's and
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Herter's tests (9) indicating that melanin formation is stopped prior to the for-
mation of indole derivatives such as hallachrome. (5) In the absence of enzyme,
p-benzylhydroquinone does not interfere with melanin formation either slowly
from dopa' by atmospheric oxithtion or from tyrosine as it occurs under the
influence of ultra-violet light (10).
The fact that p-benzylhydroquinone can itself be oxidized by the enzyme sug-
gests that the mechanism of melanin inhibition in its presence might be a com-
petitive one. However, it is rather difficult to accept this interpretation of inhibi-
tion being a simple competitive one in the sense that enzyme is firmly occupied
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FIG. 3. Oxygen uptake in systems containing 0.5 cc. enzyme and one micromole tyrosine
as substrate. In addition one micromole of various aromatic amines present for different
curves as follows: A—sodium sulfanilamide; C—o-aminobenzoic acid; E—1 , 2-naphthylene-
diamine dihydrocliloride; F—p-aminophenol; G—o-phenylene-diamine dihydrochioride and
copper sulfate; H—o-phenylenediamine dihydrochioride; I—p-phenylenediamine dihydro-
chloride; and J—p-aminobenzoic acid. For Curve B there were three micromoles of aniline.
Curve D represents oxygen uptake by the tyrosinase—tyrosine system alone.
and blocked by a false substrate because enzymatic tyrosine oxidation was not
reduced in the presence of p-benzylhydroquinone except possibly where a large
excess was used. The situation can perhaps better be pictured as a simultaneous
oxidation of both tyrosine and p-benzylliydroquinone with neither substance
occupying positions on the enzyme which excludes the other.
Aromatic Amines
Aromatic amines have been believed to inhibit melanin formation by combin-
ing with dopa-quinone and thus stopping the reaction at that stage (see Fig. 1)
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(2, 11). Figures 3 and 4 illustrate the actions of several of this group of com-
pounds on enzyme-tyrosine and enzyme-dopa systems. In these experiments
0.5 cc. of enzyme and one micromole each of the substrates and inhibitors were
used except for three micromoles in the case of aniline. From the results it is
evident that the modifying effects of the aromatic amines cannot here be simply
explained on the basis of removal of dopa-quinone. Not only are there wide
differences in inhibitory activity among the different amines (e.g.—no inhibition
by three micromoles of aniline and marked inhibition by p-phenylenediamine;
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Fm. 4. Oxygen uptake data for systems containing 0.5 cc. enzyme and one micromole
dopa. In addition there was present for Curve A one micromole 1,2-naphthylenediamine
dihydrochioride, for C one micromole para-aminobenzoic acid, and for curve D one micro-
mole o-phenylenediamine dihydrochioride.
no inhibition with 1, 2-naphthylenediamine yet considerable inhibition with
o-phenylenediamine) but also those compounds that do inhibit or delay oxygen
uptake with tyrosine are much less effective in doing so when dopa is the sub-
strate. Possibly some of these substances inhibit by binding copper which is
essential for enzyme activity. As can be seen in the case of o-phenylenediamine
an excess of copper partially overcomes the inhibition.
A few additional points worthy of special mention are: (1) the remarkable
complete inhibition of tyrosinase activity produced by para-aminobenzoic acid
which is not reversible by excess copper and which is in definite contrast to the
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lack of inhibition in the presence of ortho-aminobenzoic acid; (2) the differences
between the effects of o-phenylenediamine and p-phenylenediamine----the for-
mer prolongs the induction period while the latter shortens it and yet the latter
inhibits the rate of oxygen consumption more markedly; and (3) the lack of
inhibition by sodium sulfanilamide which is unlike the sulfonamide effects pre-
viously reported in non-mammalian tyrosinase-tyrosine systems (12, 13).
Miscellaneous
Reducing agents such as ascorbic acid, hydroquinone, hydrol and p-amino-
phenol in equimolar concentration were effective in shortening the induction
period of tyrosine oxidation with the enzyme used here. However, other anti-
oxidants such as the tocopherols even in large amounts had no apparent effect
on this enzymatic tyrosine oxidation and p-hydroxyphenylglycine though it did
not shorten the induction period nevertheless reduced the rate of oxygen uptake.
This action of p-hydroxyphenylglycine was similar to that of copper binding
agents such as cysteine, arginine, thiourea, and alpha-benzoin oxime. The effects
of all of these copper binding agents on the tyrosine oxidation studied here were
reversed by excess copper.
SUMMARY
Tyrosinase extracts were prepared from mouse melanomas of the Cloudman
S-91 variety. Increasing tyrosine concentrations prolonged the latent period for
activity of this preparation while increasing dopa concentrations shortened this
period.
Various substances were tested for their ability to modify the action of this
enzyme extract. Para-benzylhydroquinone shortened the latent period for tyro-
sine oxidation and with low enzyme concentrations inhibited oxygen uptake
while with high enzyme concentrations accelerated it. Para-bensyihydroquinone
was itself slowly oxidized by action of the enzyme. The final product of tyrosine
oxidation in the presence of para-benzylhydroquinone was a soluble red sub-
stance which gave negative indole tests. The interpretation that p-benzylhydro-
quinone inhibits melanin formation by competition with tyrosine for the enzyme
could not be entirely supported.
Among several aromatic amines tested there were wide variations in ability
to inhibit the action of this tyrosinase on tyrosine and dopa oxidation. In general
these agents were less effective in inhibiting enzymatic oxidation with dopa than
with tyrosine. Para-aminobensoic acid proved to be the most active inhibitor in
this group. This was in contrast to the lack of inhibition from ortho-aminoben-
zoic acid and sodium sulfanilamide. These results are at variance with the con-
cept that aromatic amines inhibit melanin formation merely by combining with
dopa-quinone.
Several reducing agents effectively shortened the latent period for tyrosine
oxidation. However, tocopherols and p-hydroxyphenylglycine were exceptions
in this regard.
The enzyme inhibiting action of several copper binding agents was noted and
found to be reversible by addition of excess copper.
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DISCUSSION
DR. SAMUEL M. PECK: I wish to thank Dr. Rothman and his associates for
the painstaking work which they have been carrying on for the last few years
which has cast a great deal of light on the mechanism of melanin formation. It
is very often difficult to reconcile in vitro experiments with what is known of the
physiology of melanin formation.
In 1932, I was able to demonstrate, in cooperation with Sobotka and Kahn,
that dioxyphenylalanine oxidase shows an absolute specificity for levorotatory
dioxyphenylalanine. We could also show that the dioxyphenylalanine oxidase
was an individual enzyme and was identical with neither tyrosinase nor with
polyphenolase. ("Optical Specificity of Dioxyphenylalanine Oxidase", Arch. of
Dermat. & Syph. 26: 499—503 (Sept) 1932). However, even with the levorota-
tory compound, we were unable to influence pigment formation in vivo. While
it has always been assumed that the mechanism of melanin formation is the same
in the hair and in the epidermis on the basis of Bloch's dopa reaction, again cer-
tain observations in vivo seem to not quite follow the in vitro experiments. In
1941, Lewin and I ("Pigment Studies and Skin Grafts on Experimental Animals",
Jour. of Invest. Dermat., 4: 483 (Dee) 1941) in working with changes in skin
grafts noted that when small areas of black and white skin in guinea pigs were
interchanged, the transplantation of a pigmented graft into an area of white skin
resulted in pigmentation in the host epidermis surrounding the graft. After trans-
plantation of a white skin graft into a pigmented area, the graft became pig-
mented. However, the hair which was transplanted with the graft remained un-
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changed in both instances. I wonder if this may not mean a difference in the
mechanism of pigment formation between the epidermis and the hair papillae.
The specificity of the pigment reaction is further demonstrated by the sharp
and distinct action of mono benzyl ether of hydroquinone. The slightest change
in the formula such as the use of di-benzyl compound resulted in the failure to
cause interference with pigment formation. When we consider all this evidence,
I do not believe that it is just a question of competition for oxygen which ex-
plains the effects of the hydroquinone compounds. The explanation is probably
not so simple and it must be quite specific.
DR. THEODORE CORNBLEET: Does para-aminobenzoic acid act here by virtue
of its light-screening properties? Were the experiments carried out in darkness
as well as in the light?
DR. ALLAN L. LORINcz: (Closing Discussion): I want to thank Dr. Peck for
his discussion and I agree entirely with what be has to say. In answer to Dr.
Cornbleet, light plays no role in the experiments performed here. All the reac-
tions involved are to the best of my knowledge non-photochemical and occur
equally well in the dark or light. Furthermore, the enzyme preparation itself
is a very dark substance and any additional light screening effect of para-amino-
benzoic acid would be insignificant in its presence.
